U.S. District Court for the Southern District of California granted Amylin Pharmaceuticals a temporary restraining order (TRO) related to its litigation with respect to the Amylin / Lilly diabetes collaboration agreement...
Researchers at Joslin Diabetes Center have identified an enzyme called PKC-delta as an important molecular modifier for development of insulin resistance, diabetes and fatty liver in mice. They also have found evidence suggesting a similar role for the enzyme in humans...
Spring-Set Health Solutions Ltd., a subsidiary of Israel based company D. Medical Industries Ltd, has received a medical device license to market its Spring™ Universal Infusion Sets (formerly "Lighty DD Infusion Sets") in Canada...
The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Asante Solutions' Pearl Insulin Pump. The pump has also received the CE Mark, a European proof of conformity that certifies the product meets EU safety, health and environmental requirements...
Amylin Pharmaceuticals announced that it has filed a lawsuit against Eli Lilly. Amylin alleges Lilly is engaging in anticompetitive activity and breaching its strategic alliance agreements to maximize commercialization of exenatide currently marketed as BYETTA® (exenatide) injection...
Abbott's new FreeStyle InsuLinx Blood Glucose Monitoring System with insulin calculator has received CE Mark (Conformité Européenne).The InsuLinx System is the first blood glucose monitoring device from Abbott that includes a mealtime (bolus) insulin calculator for calculating suggested insulin doses. The new system..
The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals have entered into a research collaboration agreement to provide financial support for a series of clinical studies to investigate the feasibility of mixing pramlintide...
Biodel announced that an independent investigator initiated a pump trial of Biodel's two ultra-rapid-acting formulations of recombinant human insulin. Biodel's formulations, BIOD-105 and BIOD-107, are designed to result in more rapid insulin action compared to currently marketed mealtime insulin analogs...
Global sports organization Team Type 1, the official parent company of the Team Type 1- sanofi aventis professional men’s cycling team, announced the launch a clinical study at the Amgen Tour of California. The pioneering study conducted by the Team Type 1 Diabetes Sports Research Institute, will assess blood glucose levels of elite cyclists...
The U.S. Food and Drug Administration (FDA) has approved Boehringer Ingelheim and Eli Lilly's type 2 diabetes drug Tradjenta (linagliptin) as a medication used along with diet and exercise to lower blood sugar in adult patients.
The drug can be used as monotherapy or in combination with other commonly prescribed medications...